Sign in
CompletedNo phase

Smartphone Sensors to Assess Symptom Relief in Patients With Social Anxiety Disorder Undergoing Treatment

Key facts

Who runs it
Tel Aviv University
Where
Israel1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
24 Nov 2024
Ended
30 Jul 2025
Type of study
Interventional
Treatments tested
  • Gaze-Contingent Music Reward Therapy (GC-MRT
Record updated
8 September 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Normal or corrected vision, without color blindness
  • A primary diagnosis of social anxiety disorder (based on clinician assessment (LSAS), a MINI interview, and an LSAS score above 50)
  • Age range of 18-65
  • Ownership of a smartphone that supports the digital monitoring App

Who cannot take part

  • Prior experience with GC-MRT
  • Concurrent treatment (pharmacological or psychosocial)
  • A current diagnosis of post-traumatic stress disorder (PTSD)
  • A current or past diagnosis of psychosis or bipolar disorder
  • Neurological disorder (e.g., epilepsy, brain injury)
  • Severe suicidal ideation
  • Substance or alcohol addiction
  • Pregnancy
  • Insufficient Hebrew proficiency (unable to complete a clinical interview and/or self-report symptoms and/or perform cognitive tasks)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this study is to examine if a digital behavior-based framework, utilizing the BHQ app, can effectively monitor social anxiety symptoms and evaluate the symptom-reducing impact of attentional training for adults (18-65) with social anxiety disorder (SAD), compared to traditional clinical questionnaires and self-reports.

Read full original descriptionShow less

The main questions it aims to answer are:

1. Can the BHQ app provide a reliable digital measure of social anxiety symptoms? 2. Does GC-MRT significantly reduce symptoms of social anxiety as measured through BHQ app monitoring and standard assessment tools?

Researchers will compare the digital BHQ measurements to traditional clinical assessments to see if the app-based measurements is effective in monitoring symptoms relief.

Participants will:

* Complete an initial clinical interview and self-report questionnaires. * Engage in a computer-based "free-viewing" task for baseline attention assessment using eye tracking. * Connect to the BHQ app for continuous monitoring throughout the study. * Undergo attentional training, GC-MRT. * Complete weekly SPIN assessments. * Undergo Final evaluation two weeks post-treatment including repeated clinical interviews, self-reports, and the computer-based task to assess changes in attention patterns and symptom reduction.

The group in the trial

  • Starting GC-MRT training after randomized allocation of period of time after assesmentTreatment being tested

    Gaze-Contingent Music Reward Therapy (GC-MRT) is a treatment method for adults with social anxiety disorder found to be effective in reducing social anxiety in various RCTs. This method includes a computerized cognitive training to redirect threat-related attention patterns. Time period between Pre assessment and start of GC-MRT is randomly assigned (1 week/ 2 weeks/ 3 weeks) to create a multiple baseline design.

    Treatment: Gaze-Contingent Music Reward Therapy (GC-MRT

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Using Smartphone Sensors to Assess Symptom Relief in Patients With Social Anxiety Disorder Undergoing Gaze Contingent Music Reward Therapy (GC-MRT)
Publications
Record updated
8 September 2025